Profile
Full Name
Mineralys Therapeutics, Inc.Ticker Symbol
MLYSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 10, 2023Indexes
Not includedWebsite
http://mineralystx.comEmployees
51Key Details
Price
$13.34(-5.32%)
Market cap
$865.45M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.66(-83.92% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Mineralys Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 2, 25 HC Wainwright & Co.
BuyMar 10, 25 HC Wainwright & Co.
BuyFeb 24, 25 Guggenheim
BuyFeb 13, 25 HC Wainwright & Co.
BuyFeb 13, 25 Goldman Sachs
BuyNov 12, 24 HC Wainwright & Co.
BuyOct 31, 24 HC Wainwright & Co.
BuyAug 15, 24 HC Wainwright & Co.
BuyJul 10, 24 HC Wainwright & Co.
BuyApr 2, 24 Goldman Sachs
BuyInstitutional Ownership
- What is the ticker symbol for Mineralys Therapeutics?
- Does Mineralys Therapeutics pay dividends?
- What sector is Mineralys Therapeutics in?
- What industry is Mineralys Therapeutics in?
- What country is Mineralys Therapeutics based in?
- When did Mineralys Therapeutics go public?
- Is Mineralys Therapeutics in the S&P 500?
- Is Mineralys Therapeutics in the NASDAQ 100?
- Is Mineralys Therapeutics in the Dow Jones?
- When was Mineralys Therapeutics's last earnings report?
- When does Mineralys Therapeutics report earnings?
- Should I buy Mineralys Therapeutics stock now?
What is the ticker symbol for Mineralys Therapeutics?
The ticker symbol for Mineralys Therapeutics is NASDAQ:MLYS
Does Mineralys Therapeutics pay dividends?
No, Mineralys Therapeutics does not pay dividends
What sector is Mineralys Therapeutics in?
Mineralys Therapeutics is in the Healthcare sector
What industry is Mineralys Therapeutics in?
Mineralys Therapeutics is in the Biotechnology industry
What country is Mineralys Therapeutics based in?
Mineralys Therapeutics is headquartered in United States
When did Mineralys Therapeutics go public?
Mineralys Therapeutics's initial public offering (IPO) was on February 10, 2023
Is Mineralys Therapeutics in the S&P 500?
No, Mineralys Therapeutics is not included in the S&P 500 index
Is Mineralys Therapeutics in the NASDAQ 100?
No, Mineralys Therapeutics is not included in the NASDAQ 100 index
Is Mineralys Therapeutics in the Dow Jones?
No, Mineralys Therapeutics is not included in the Dow Jones index
When was Mineralys Therapeutics's last earnings report?
Mineralys Therapeutics's most recent earnings report was on Feb 12, 2025
When does Mineralys Therapeutics report earnings?
The next expected earnings date for Mineralys Therapeutics is May 9, 2025
Should I buy Mineralys Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions